Tag: leo

LEO receives marketing authorisation application for delgocitinib

by John Pinching | Aug 21, 2023 | News | 0

The treatment is indicated for adults with moderate-to-severe chronic hand eczema

ICON and LEO Pharma join forces on clinical trial mission

by John Pinching | Mar 10, 2023 | News | 0

Collaboration will concentrate on launching and running studies within medical dermatology

LEO Pharma receives positive CHMP opinion of Adtralza

by John Pinching | Sep 20, 2022 | News | 0

Therapy is for the treatment of adolescents with moderate-to-severe atopic dermatitis

Scotland approves NHS funding for Ibrance, Cerdelga and Invicorp

by Selina McKee | Dec 12, 2017 | News | 0

The latest batch of decisions by the Scottish Medicines Consortium has given patients with certain forms of breast cancer, Gaucher disease and erectile dysfunction new treatment options on the NHS.

FDA advisors back brodalumab with suicide risk plan

by Selina McKee | Jul 20, 2016 | News | 0

Valeant’s skin jab brodalumab has taken a big step towards US approval after regulatory advisors backed the drug for adult patients with moderate-to-severe plaque psoriasis.